SL is an entrepreneur with a multidisciplinary background in biological sciences, technical textile engineering (MEng) and biomaterials (MSc). SL has 16 years of experience with silk and the vascular sector, previously leading an Oxford spin-out. SL co-founder OSPT after discovering the impact infections had on vascular patients, the unrealised potential of phages and the disruptive prospects of a platform technology combining silk and phages.

Dr Magnan has hands on expertise in silk, vascular, microbiology and genetics. LM developed small diameter tissue-engineered haemodialysis grafts based on cell-assembled extracellular matrix during her PhD in Bordeaux France, with Dr. Nicolas L’Heureux as supervisor. She subsequently applied her vascular graft knowledge to silk-based grafts when working with Ms Lesage in a previous Oxford-based company. She joined OSPT in January 2020.

Mr Gilbert is vascular access lead surgeon at Oxford University hospital and has been elected president of the British Vascular Access Society (VASBI) in 2019. Interested in novel, disruptive vascular technologies improving outcome for patients, he is a key advisor for several leading companies in the vascular field, and has been involved in the first UK trials of several new technologies over the past 10 years.

A pharmacist by training, DLP is a seasoned entrepreneur with extensive, hands on experience in the development and access to market of both pharmaceutical and medical device products. He has held a number of director and executive officer posts in small and major multinational companies. DLP is now co-founder of the LRE-System, an Oxford-based disruptive elbow-repair device company he has recently taken through CE marking.